![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Basf Aktiengesellschaft Limburgerhof De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Thiamine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1994-005 - Rev 02
This Chemical Type CEP, issued on October 06, 2004, remains in force until December 15, 2005, ensuring its reliability within the pharmaceutical industry.
Substance Number 303 associated with this CEP further emphasizes